KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Total Liabilities: 2018-2024

Historic Total Liabilities for Aurinia Pharmaceuticals (AUPH) over the last 7 years, with Dec 2024 value amounting to $173.2 million.

  • Aurinia Pharmaceuticals' Total Liabilities rose 0.25% to $161.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.8 million, marking a year-over-year increase of 0.25%. This contributed to the annual value of $173.2 million for FY2024, which is 1.80% up from last year.
  • As of FY2024, Aurinia Pharmaceuticals' Total Liabilities stood at $173.2 million, which was up 1.80% from $170.1 million recorded in FY2023.
  • In the past 5 years, Aurinia Pharmaceuticals' Total Liabilities registered a high of $173.2 million during FY2024, and its lowest value of $55.9 million during FY2020.
  • For the 3-year period, Aurinia Pharmaceuticals' Total Liabilities averaged around $136.2 million, with its median value being $170.1 million (2023).
  • Data for Aurinia Pharmaceuticals' Total Liabilities shows a peak YoY skyrocketed of 160.00% (in 2023) over the last 5 years.
  • Over the past 5 years, Aurinia Pharmaceuticals' Total Liabilities (Yearly) stood at $55.9 million in 2020, then grew by 14.96% to $64.3 million in 2021, then grew by 1.79% to $65.4 million in 2022, then skyrocketed by 160.00% to $170.1 million in 2023, then rose by 1.80% to $173.2 million in 2024.